As of Apr 28
| -0.01 / -0.43%|
The 2 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 6.50, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +182.61% increase from the last price of 2.30.
The current consensus among 3 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.